Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000116384 | SCV000303934 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Cardiovascular Research Group, |
RCV000256290 | SCV000322835 | benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Illumina Laboratory Services, |
RCV000295735 | SCV000427148 | likely benign | Familial hypobetalipoproteinemia 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001094640 | SCV000427149 | likely benign | Hypercholesterolemia, autosomal dominant, type B | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000116384 | SCV000519196 | benign | not specified | 2016-10-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory of Genetics and Molecular Cardiology, |
RCV000256290 | SCV000588420 | benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Color Diagnostics, |
RCV000256290 | SCV000687213 | benign | Hypercholesterolemia, familial, 1 | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000256290 | SCV001135626 | benign | Hypercholesterolemia, familial, 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001837455 | SCV001728418 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001094640 | SCV001774906 | benign | Hypercholesterolemia, autosomal dominant, type B | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000295735 | SCV001774907 | benign | Familial hypobetalipoproteinemia 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408617 | SCV002716517 | benign | Cardiovascular phenotype | 2015-12-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
GENin |
RCV000771026 | SCV005061704 | benign | Familial hypercholesterolemia | 2024-06-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004710496 | SCV005262645 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116384 | SCV000150308 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Pharmacogenomics Lab, |
RCV000845574 | SCV000889939 | drug response | Warfarin response | 2010-08-31 | no assertion criteria provided | research | In patients receiving warfarin after mechanical valve replacement, G allele carriers of rs679899 had 6.4 times increased risk of bleeding. |
Diagnostic Laboratory, |
RCV000116384 | SCV001739556 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000116384 | SCV001925630 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000771026 | SCV003836784 | benign | Familial hypercholesterolemia | 2023-02-09 | no assertion criteria provided | clinical testing |